Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by janejanesandpiper Homepage – 2021-05-26 16:26 (123 d 14:29 ago) – Posting: # 22368
Views: 544

SARS-COV-2 is optimized to bind to the ACE2 receptors. These receptors are all over the epithelial lining of your blood vessels (vascular system). Your blood vessels are the lifeline for ALL your organs. So when the virus “corrodes” the cells lining the blood vessels, you can see that clotting is rampant.

Nitric Oxide (NO) prevents the oxidative stress that is caused by this virus to the blood vessel linings. NO supplementation (at hospitals through gas tanks is being done).

This video explains it all.
https://youtu.be/22Bn8jsGI54


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Monday 06:56 CEST (Europe/Vienna)

In the beginner’s mind there are many possibilities.
In the expert’s mind there are few.    Shunryu Suzuki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5